Startups
Bellco, an Italian company with more than 40 years’ experience, was one of the pioneers in the history of haemodialysis. Bellco operated worldwide, offering systems for the treatment of renal failure, multiple organ failure, sepsis and cardiac decompensation. Its mission was to satisfy the needs of patients and experts through innovation, research and the development of advanced and personalized therapies for nephrology, intensive care and cardiology patients.
Bellco was acquired by Medtronic in February 2016.
Bellco was acquired by Medtronic in February 2016.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 22, 2013 | Bellco Receives Investment from Amadeus Capital Partners | Bellco, a Mirandola, Italy-based developer of equipment for haemo-dialysis used in kidney disease, received an investment from Amadeus Capital Partners. The amount of the transaction was not disclosed. Amadeus Capital Partners, which joined... |
| Blood purification device for ICU patients seeks to treat root cause of sepsis | Medical device company CytoSorbents (OTC: CTSO) has developed a filtration system for the blood to treat the root cause of sepsis for some of the most vulnerable patients in a hospital — those in the intensive care unit. Its device uses pol... |
Reviews 0
FAQ about Bellco
What has the press written about Bellco?
Parsers VC has collected 3 articles mentioning Bellco, among them “Bellco Receives Investment from Amadeus Capital Partners” (Feb 22, 2013) and “Blood purification device for ICU patients seeks to treat root cause of sepsis”.
Is Bellco still active?
Yes, Bellco is active; its latest activity on Parsers VC dates from May 24, 2013.